300142 Walvax Biotechnology
- 13.54
- -0.80-5.58%
Walvax Biotechnology News
Watson Biotech: Response to the review inquiry letter on the application of Yunnan Watson Biotechnology Co., Ltd. to issue convertible corporate bonds to an unspecified target
Watson Biotech: Reminder Notice Concerning Responses to Audit Inquiries on Applications for Issuance of Convertible Corporate Bonds to Unspecified Targets and Updates to Application Documents such as Prospectus
Watson Biotech: Response from Daxin Certified Public Accountants (Special General Partnership) to the review inquiry letter of Yunnan Watson Biotechnology Co., Ltd.\'s application to issue convertible corporate bonds to an unspecified target
Watson Biotech: Announcement on changing the independent financial advisor organizer of the company's project to issue shares to buy assets and raise supporting capital
Watson Biotech: Feasibility analysis report on the use of funds raised by issuing convertible corporate bonds to unspecified targets
Watson Biotech: An indicative announcement on the disclosure of plans to issue convertible corporate bonds to unspecified targets
Watson Biotech: Announcement on Issuance of Convertible Corporate Bonds to Unspecified Targets to Diluted Immediate Returns and Proposed Compensatory Measures and Related Entities' Commitments
Watson Biotech: An empirical analysis report on issuing convertible corporate bonds to unspecified targets
Watson Biotech: 2021 Annual Equity Distribution Implementation Notice
Watson Biotech: Announcement on 2021 Profit Distribution Plan
Watson Biotech: Announcement on relinquishing priority purchase rights of Shanghai Zerun Biotechnology Co., Ltd. to be transferred by Huisheng (China) Investment Co., Ltd.
Watson Biotech: An indicative announcement on matters relating to the company's intention to issue overseas listed foreign shares (H shares) and list them on the main board of the Hong Kong Stock Exchange
Watson Biotech: Special explanation on proposed profit distribution in 2019
Watson Biotech: Announcement on relinquishing the priority purchase rights of Shanghai Zerun Biotechnology Co., Ltd. to be transferred by Suzhou Jinsheng Shuoda Investment Center (Limited Partnership)
Watson Biotech: Announcement on progress in the collection of equity transfers
Watson Biotech: Announcement on progress in the recovery of equity transfer funds
Watson Biotech: Announcement on the signing of the equity transfer agreement of Jiahe Biopharmaceutical Co., Ltd.
Watson Biotech: Announcement on the transfer of shares in Shanghai Watson Pharmaceutical Technology Co., Ltd.
Watson Biotech: Announcement on Transfer of Shares in Yunnan Pengqiao Pharmaceutical Co., Ltd.
Watson Biotech: Announcement on Transfer of Shares in Changchun Huapu Biotechnology Co., Ltd.
No Data
